Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
SWAN-PSMA-1007 1 ml / 10 ml, Injektionslösung 15 mL
Drug
SWAN-PSMA-1007, Injektionslösung
PET-Diagnose von PSMA-positivem Prostatakrebs
17.01.9. – tumourdiagnostics
HAM – Human medicine
LSINJ – Solution for injection
R – radiopharmaceutic products
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
6/11/2024
6/10/2029
Dosage strength
SWAN-PSMA-1007 1 ml / 10 ml, Injektionslösung
PET-Diagnose von PSMA-positivem Prostatakrebs
01
Z – approved
Package
No information made available
A/NR – Authorised / not referenced
15 mL vial(s)
001
Z – approved
Declaration
Component
222 MBq (18F)-PSMA-1007
dinatrii phosphas
kalii dihydrogenophosphas
natrii chloridum
kalii chloridum
0.075 ml ethanolum
60 mg ethanolum
natrii ascorbas
aqua ad iniectabile
4.6 mg natrium
kalii dihydrogenophosphas
natrii chloridum
kalii chloridum
0.075 ml ethanolum
60 mg ethanolum
natrii ascorbas
aqua ad iniectabile
4.6 mg natrium
Authorisation holder
7601001398085
SWAN Isotopen AG
Anna-Seiler-Allee 24
3010 Bern (BE)
Anna-Seiler-Allee 24
3010 Bern (BE)
Date of revision of the text
11/11/2024
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.